ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,101Medicare Part D Prescriptions Filled, Including Refills

Rank: 129 out of 2343

$1.16M Total Retail Price of All Prescriptions

Rank: 69 out of 2343

1,031 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 1,031 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

12% of this provider’s 1,031 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 13,342 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 979 860 1 1
LEVOTHYROXINE SODIUM 732 645 2 2
HYDROCODONE-ACETAMINOPHEN 626 368 S3 3 13
LISINOPRIL 552 442 4 3
AMLODIPINE BESYLATE 535 491 5 5
OMEPRAZOLE 502 392 6 4
METFORMIN HCL 440 366 7 9
METOPROLOL TARTRATE 380 337 8 7
ZOLPIDEM TARTRATE 357 293 9 24
HYDROCHLOROTHIAZIDE 347 310 10 11
ATENOLOL 298 268 11 12
ATORVASTATIN CALCIUM 268 260 12 10
FUROSEMIDE 250 182 13 6
WARFARIN SODIUM 248 189 14 8
LOSARTAN POTASSIUM 178 173 15 19
GABAPENTIN 170 123 16 16
CLOPIDOGREL 167 140 17 26
PRAVASTATIN SODIUM 164 146 18 15
TRAMADOL HCL 164 114 18 25
ALENDRONATE SODIUM 162 148 20 28
DIOVAN 157 129 21 23
OXYCODONE HCL 155 0 S2 22 67
LOSARTAN-HYDROCHLOROTHIAZIDE 150 148 23 64
METOPROLOL SUCCINATE 148 136 24 14
PANTOPRAZOLE SODIUM 144 109 25 22
ADVAIR DISKUS 143 104 26 34
GLIMEPIRIDE 131 112 27 45
TAMSULOSIN HCL 127 117 28 29
CITALOPRAM HBR 127 100 28 17
SPIRONOLACTONE 118 82 30 65
PREDNISONE 115 86 31 37
CRESTOR 113 90 32 30
DONEPEZIL HCL 112 112 33 21
ALLOPURINOL 112 86 33 31
MORPHINE SULFATE ER 112 15 S2 33 142
SPIRIVA 111 78 36 48
JANUVIA 107 101 37 50
EVISTA 106 106 38 128
LOVASTATIN 105 70 39 47
LANSOPRAZOLE 101 100 40 162
PLAVIX 101 87 40 38
LISINOPRIL-HYDROCHLOROTHIAZIDE 100 80 42 42
DIOVAN HCT 99 91 43 63
SERTRALINE HCL 91 57 44 20
CYMBALTA 91 53 44 74
NEXIUM 90 69 46 33
CYCLOBENZAPRINE HCL 88 30 R 47 109
OXYCODONE-ACETAMINOPHEN 81 36 S2 48 49
AZITHROMYCIN 80 60 49 39
RAMIPRIL 79 68 50 90
DIPHENOXYLATE-ATROPINE 78 54 51 329
FLUTICASONE PROPIONATE 78 50 51 46
FENOFIBRATE 77 48 53 94
CLONIDINE HCL 76 52 54 70
CELEBREX 76 72 54 71
LANTUS 75 53 56 51
ENALAPRIL MALEATE 73 68 57 58
METHADONE HCL 71 0 S2 58 242
TRICOR 70 43 59 96
POTASSIUM CHLORIDE 70 70 59 18
ACTOS 70 65 59 125
HUMALOG 68 46 62 131
DIGOXIN 68 66 62 35
SYNTHROID 68 63 62 40
IBUPROFEN 67 24 65 75
BENICAR HCT 66 66 66 156
TRIAMTERENE-HCTZ 66 61 66 57
PAROXETINE HCL 66 46 66 66
OXYCONTIN 61 17 S2 69 138
LOVAZA 61 21 69 113
LEVOFLOXACIN 61 47 69 106
TRIAMCINOLONE ACETONIDE 60 37 72 137
VENLAFAXINE HCL ER 60 32 72 87
GLYBURIDE 58 38 R 74 62
ISOSORBIDE MONONITRATE ER 58 41 74 32
ZETIA 56 43 76 52
BISOPROLOL-HYDROCHLOROTHIAZIDE 55 52 77 151
INSULIN SYRINGE 54 33 78 102
NADOLOL 53 24 79 297
QUETIAPINE FUMARATE 53 14 79 77
CARBIDOPA-LEVODOPA 52 52 81 85
SULFAMETHOXAZOLE-TRIMETHOPRIM 51 47 82 120
VESICARE 51 51 82 145
CARISOPRODOL 51 0 R 82 176
PROAIR HFA 50 27 85 86
NAPROXEN 50 29 85 108
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 24, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.